QuickCAS is a Rapid, Easy-to-use, Fully automated and Low-cost analysis system, which aimed to provide quick detection of infectious pathogens in clinical samples for clinicians and patients.
發展階段｜STAGE OF DEVELOPMENT
Ready to launch
- QuickCAS combined the revolutionary microrobotic sensing probe (microrobot) and automation technology and has the following advantages while comparing to current gold standard in detecting C. diff toxin:
- Lower cost (HK$50 vs HK$300)
- Shorter processing time (15-30 min vs 2-4 hrs)
- Lowest workload (Full automation vs cumbersome procedures)
- Ease of use, only 4 simple steps (No requirements on specialists, complicated equipment, control samples and extra chemicals)
- Easier transportation and storage (Microrobots are stable under room temperature)
- By analyzing the changes in the fluorescence signal of the microrobots under magnetic actuation, presence of pathogen in patients’samples can be determined.
- The above technology was published in Science Advances (AAAS) in 2019. In addition, the microrobots can be further modified to detect various toxin/virus/bacteria with high selectivity.
- This technology has granted 1 US non-provisional patent and filed 1 Chinese patent.
- To help doctors utilize this innovative technology, we established MicroMag Healthcare, a spin-off company, to commercialize our research result. We are now working towards the clinical trial of our C. diff sensing probe and studying the application of QuickCAS for multiple pathogens including the COVID-19 with the Institute of Digestive Disease (IDD) and Department of Microbiology, CUHK.
如何解決市場痛點｜RESPONSE TO MARKET PAIN POINTS
As the COVID-19 pandemic rages worldwide, rapid testing with automated detection systems is urged for effective diagnosis and infection control. Delayed diagnosis not only further burdens the healthcare system but might also costs patients’ life. MicroMag aims to provide clinicians/patients with instant, accurate and effortless diagnosis to prevent infectious outbreak and saving lives through our innovative microrobotic technology.
- 資金 Funding
- 創業夥伴 Partners
- 產品回饋 Product Feedback
- 曝光機會 Visibility and Exposure